Cite
HARVARD Citation
Akbarzadeh, R. et al. (2023). Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus. Current opinion in rheumatology. 35 (2), pp. 98-106. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Akbarzadeh, R. et al. (2023). Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus. Current opinion in rheumatology. 35 (2), pp. 98-106. [Online].